Influence of obesity on periodontitis progression is conditional on interleukin-1 inflammatory genetic variation

Journal of Periodontology

Volumn 88, Issue 1, 2017, Pages 59-68

  Wilkins, Leon M ^a   Kaye, Elizabeth K ^b,c   Wang, Hwa Ying ^a   Rogus, John ^a   Doucette Stamm, Lynn ^a   Kornman, Kenneth ^a   Garcia, Raul I ^b,c  

^a Interleukin Genetics ^*  (United States)

^b BOSTON UNIVERSITY   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Cytokines; Diagnosis; Genetics; Obesity; Periodontitis

Indexed keywords

INTERLEUKIN 1;

ADULT; AGED; ANTHROPOMETRY; COMPLICATION; DISEASE EXACERBATION; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OBESITY; PERIODONTITIS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VETERAN;

ADULT; AGED; ANTHROPOMETRY; DISEASE PROGRESSION; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-1; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PERIODONTITIS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VETERANS;

EID: 85007270623     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2016.160408     Document Type: Article

References (50)

1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ; CDC Periodontal Disease Surveillance workgroup. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91:914-920.
2. Page RC, Kornman KS. The pathogenesis of human periodontitis: An introduction. Periodontol 2000 1997;14:9-11.
3. Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011;3:5304-5318.
4. Reynolds MA. Modifiable risk factors in periodontitis: At the intersection of aging and disease. Periodontol 2000 2014;64:7-19.
5. Giannobile WV, Braun TM, Caplis AK, Doucette-Stamm L, Duff GW, Kornman KS. Patient stratification for preventive care in dentistry. J Dent Res 2013;92:694-701.
6. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T. Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol 2004;75:236-242.
7. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol 2013; 84(Suppl. 4)S113-S134.
8. Wu X, Offenbacher S, López NJ, et al. Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ethnicities. J Periodontal Res 2015;50:52-61.
9. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013;62:59-94.
10. Saito T, Shimazaki Y, Kiyohara Y, et al. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: The Hisayama study. J Periodontal Res 2005;40:346-353.
11. Nascimento GG, Leite FR, Do LG, et al. Is weight gain associated with the incidence of periodontitis? A systematic review and meta-analysis. J Clin Periodontol 2015;42:495-505.
12. Suvan J, Petrie A, Moles DR, et al. Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res 2014;93:49-54.
13. Goncxalves TE, Zimmermann GS, Figueiredo LC, et al. Local and serum levels of adipokines in patients with obesity after periodontal therapy: One-year follow-up. J Clin Periodontol 2015;42:431-439.
14. Keller A, Rohde JF, Raymond K, Heitmann BL. Association between periodontal disease and overweight and obesity: A systematic review. J Periodontol 2015;86:766-776.
15. Meisel P, Kohlmann T, Nauck M, Biffar R, Kocher T. Effect of body shape and inflammation on tooth loss in men and women. Clin Oral Investig 2016.
16. Gorman A, Kaye EK, Apovian C, Fung TT, Nunn M, Garcia RI. Overweight and obesity predict time to periodontal disease progression in men. J Clin Periodontol 2012;39:107-114.
17. Gorman A, Kaye EK, Nunn M, Garcia RI. Changes in body weight and adiposity predict periodontitis progression in men. J Dent Res 2012;91:921-926.
18. Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, Tilg H. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med 2011;17:840-845.
19. Satpathy A, Ravindra S, Thakur S, Kulkarni S, Porwal A, Panda S. Serum interleukin-1β in subjects with abdominal obesity and periodontitis. Obes Res Clin Pract 2015;9:513-521.
20. Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: A systematic review and meta-analysis. Obes Rev 2013;14:232-244.
21. Donath MY. Targeting inflammation in the treatment of type 2 diabetes: Time to start. Nat Rev Drug Discov 2014;13:465-476.
22. Pischon N, Heng N, Bernimoulin JP, Kleber BM, Willich SN, Pischon T. Obesity, inflammation, and periodontal disease. J Dent Res 2007;86:400-409.
23. Gocke C, Holtfreter B, Meisel P, et al. Abdominal obesity modifies long-term associations between periodontitis and markers of systemic inflammation. Atherosclerosis 2014;235:351-357.
24. Glass RL, Loftus ER, Kapur KK, Alman JE. Analyses of components of periodontal disease. J Dent Res 1973;52:1238-1244.
25. Schei O, Waerhaug J, Lovdal A, Arno A. Alveolar bone loss as related to oral hygiene and age. J Periodontol 1959;30:7-16.
26. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269.
27. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes Rev 2012;13:275-286.
28. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
29. Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: A systematic review and meta-analysis. J Periodontol 2010;81:1708-1724.
30. Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev 2011;12:e381-e404.
31. Jimenez M, Hu FB, Marino M, Li Y, Joshipura KJ. Type 2 diabetes mellitus and 20 year incidence of periodontitis and tooth loss. Diabetes Res Clin Pract 2012;98:494-500.
32. Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI. Metabolic syndrome and periodontal disease progression in men. J Dent Res 2016;95:822-828.
33. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: A pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190-201.
34. Bouaziz W, Davideau JL, Tenenbaum H, Huck O. Adiposity measurements and non-surgical periodontal therapy outcomes. J Periodontol 2015;86:1030-1037.
35. Shungin D, Cornelis MC, Divaris K, et al. Using genetics to test the causal relationship of total adiposity and periodontitis: Mendelian randomization analyses in the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) Consortium. Int J Epidemiol 2015;44:638-650.
36. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
37. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010;106:56-61.
38. Reinhardt RA, Stoner JA, Golub LM, et al. Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J Periodontol 2010;81:251-259.
39. Ebersole JL, Kirakodu S, Novak MJ, et al. Cytokine gene expression profiles during initiation, progression and resolution of periodontitis. J Clin Periodontol 2014;41:853-861.
40. Kinney JS, Morelli T, Oh M, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol 2014;41:113-120.
41. Dregan A, Charlton J, Chowienczyk P, Gulliford MC. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: A population-based cohort study. Circulation 2014;130:837-844.
42. Pink C, Kocher T, Meisel P, et al. Longitudinal effects of systemic inflammation markers on periodontitis. J Clin Periodontol 2015;42:988-997.
43. Wu X, Kondragunta V, Kornman KS, et al. IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. Osteoarthritis Cartilage 2013;21:930-938.
44. Thorand B, Baumert J, Döring A, et al; KORA Group. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-224.
45. Meisel P, Holtfreter B, Völzke H, Kocher T. Sex differences of tooth loss and obesity on systemic markers of inflammation. J Dent Res 2014;93:774-779.
46. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78(Suppl. 7)1387-1399.
47. Berger P, McConnell JP, Nunn M, et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002;17:171-174.
48. Rogus J, Beck JD, Offenbacher S, et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 2008;123:387-398.
49. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006;15:519-529.
50. Jouvenne P, Chaudhary A, Buchs N, Giovine FS, Duff GW, Miossec P. Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis. Eur Cytokine Netw 1999;10:33-36.